Works matching IS 09024441 AND DT 2019 AND VI 102 AND IP 2
Results: 13
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 111, doi. 10.1111/ejh.13193
- By:
- Publication type:
- Article
Back to the future: Treatment‐free remission and pregnancy in chronic myeloid leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 197, doi. 10.1111/ejh.13192
- By:
- Publication type:
- Article
CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 191, doi. 10.1111/ejh.13191
- By:
- Publication type:
- Article
Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 182, doi. 10.1111/ejh.13190
- By:
- Publication type:
- Article
Prophylaxis of chemotherapy‐induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non‐Hodgkin lymphoma (NADIR study).
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 174, doi. 10.1111/ejh.13189
- By:
- Publication type:
- Article
Phase I study of domatinostat (4SC‐202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 163, doi. 10.1111/ejh.13188
- By:
- Publication type:
- Article
Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 157, doi. 10.1111/ejh.13187
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint inhibitors: Feasibility and safety.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 150, doi. 10.1111/ejh.13186
- By:
- Publication type:
- Article
Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 143, doi. 10.1111/ejh.13185
- By:
- Publication type:
- Article
Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 131, doi. 10.1111/ejh.13183
- By:
- Publication type:
- Article
Molecular pathogenesis of acquired aplastic anemia.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 103, doi. 10.1111/ejh.13182
- By:
- Publication type:
- Article
Deferasirox in children with transfusion‐dependent thalassemia or sickle cell anemia: A large cohort real‐life experience from Turkey (REACH‐THEM).
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 123, doi. 10.1111/ejh.13180
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 101, doi. 10.1111/ejh.13114
- Publication type:
- Article